Intuitive Surgical Inc- 詳細介紹、公司背景、業務範圍、財務數據以及市場表現

關於 Intuitive Surgical Inc 公司

Intuitive Surgical, Inc. 開發、製造和銷售達芬奇手術系統和 Ion 腔內系統。該公司的產品和相關服務使醫生和醫療保健提供者能夠獲得微創治療。達芬奇手術系統由一個或多個外科醫生控制檯、一個病人側推車和一個高性能視覺系統組成。達芬奇產品分爲五類，即達芬奇手術系統、達芬奇儀器和配件、達芬奇縫合器、達芬奇能源和達芬奇視覺，包括 Firefly 熒光成像系統和達芬奇內窺鏡。該公司還提供一套全面的系統、學習和服務產品。Ion 腔內系統由一個系統推車、一個控制器、一個導管和一個視覺探頭組成。該公司將其商業產品從外科手術擴展到診斷程序，從而實現肺部微創活檢。兩種系統都使用軟件、儀器和配件。

公司簡介

公司代碼ISRG

公司名稱Intuitive Surgical Inc

上市日期Jun 13, 2000

成立日期1995

CEODr. Gary S. Guthart, Ph.D.

員工數量15638

證券類型Ordinary Share

年結日Jun 13

公司地址1020 Kifer Road

城市SUNNYVALE

上市交易所NASDAQ Global Select Consolidated

國家United States of America

郵編94086

電話14085232100

網址https://www.intuitive.com/en-us/about-us/company

公司代碼ISRG

上市日期Jun 13, 2000

成立日期1995

公司高階主管

名稱

名稱/職務

職務

持股

持股變動

Dr. Gary S. Guthart, Ph.D.

Chief Executive Officer, Director

1.27M

+1.05%

Mr. David J. Rosa

President, Director

231.87K

+5.81%

Dr. Craig H. Barratt, Ph.D.

Independent Chairman of the Board

26.16K

+3.17%

Ms. Amal M. Johnson

Independent Director

12.28K

--

Mr. Henry L. Charlton

Executive Vice President, Chief Commercial and Marketing Officer

7.73K

+157.65%

Mr. Joseph C. Beery

Independent Director

2.37K

--

Mr. Mark Preston Brosius

Senior Vice President, Chief Manufacturing and Supply Chain Officer

2.04K

-54.69%

Dr. Monica P. Reed, M.D.

Independent Director

1.61K

--

Dr. Amy L. Ladd, M.D.

Independent Director

671.00

-18.27%

Ms. Sreelakshmi Kolli

Independent Director

240.00

--

名稱

名稱/職務

職務

持股

持股變動

Dr. Gary S. Guthart, Ph.D.

Chief Executive Officer, Director

1.27M

+1.05%

Mr. David J. Rosa

President, Director

231.87K

+5.81%

Dr. Craig H. Barratt, Ph.D.

Independent Chairman of the Board

26.16K

+3.17%

Ms. Amal M. Johnson

Independent Director

12.28K

--

Mr. Henry L. Charlton

Executive Vice President, Chief Commercial and Marketing Officer

7.73K

+157.65%

Mr. Joseph C. Beery

Independent Director

2.37K

--

收入明細

單位: USD更新時間: 4月2日週三

FY2024

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022

FY2022Q4

FY2022Q3

FY2022Q2

FY2021

FY2020

FY2019

FY2018

業務USD

名稱

營收

佔比

Instruments and accessories

5.08B

60.81%

Systems

1.97B

23.54%

Services

1.31B

15.65%

地區USD

名稱

營收

佔比

U.S.

5.59B

66.92%

Outside of United states

2.76B

33.08%

業務

地區

業務USD

名稱

營收

佔比

Instruments and accessories

5.08B

60.81%

Systems

1.97B

23.54%

Services

1.31B

15.65%

股東統計

更新時間: 2月21日週五

持股股東

股東類型

持股股東

股東統計

佔比

The Vanguard Group, Inc.

8.95%

BlackRock Institutional Trust Company, N.A.

5.18%

State Street Global Advisors (US)

4.27%

T. Rowe Price Associates, Inc.

3.90%

Fidelity Management & Research Company LLC

2.93%

Other

74.77%

持股股東

股東統計

佔比

The Vanguard Group, Inc.

8.95%

BlackRock Institutional Trust Company, N.A.

5.18%

State Street Global Advisors (US)

4.27%

T. Rowe Price Associates, Inc.

3.90%

Fidelity Management & Research Company LLC

2.93%

Other

74.77%

股東類型

股東統計

佔比

Investment Advisor

43.07%

Investment Advisor/Hedge Fund

35.61%

Bank and Trust

2.46%

Research Firm

2.40%

Pension Fund

2.20%

Hedge Fund

1.76%

Sovereign Wealth Fund

1.39%

Individual Investor

0.50%

Foundation

0.15%

Other

10.46%

機構持股

更新時間: 1月19日週日

報告期間

機構數

持股數

持股佔比

持股變動

2025Q1

3377

322.64M

90.05%

-654.22K

2024Q4

3426

322.11M

90.31%

-1.17M

2024Q3

3255

319.27M

89.84%

-8.25M

2024Q2

3152

322.86M

91.02%

+572.17K

2024Q1

3116

317.58M

89.60%

-829.16K

2023Q4

3055

314.33M

89.27%

-2.70M

2023Q3

2961

312.82M

89.02%

-3.61M

2023Q2

2932

311.78M

88.97%

-2.17M

2023Q1

2848

309.16M

88.25%

-6.75M

2022Q4

2840

310.11M

87.74%

-7.77M

股東持股明細

名稱

持股數

佔比

持股變動

變動比例

公告日期

The Vanguard Group, Inc.

32.06M

8.95%

+364.96K

+1.15%

Dec 31, 2024

BlackRock Institutional Trust Company, N.A.

18.57M

5.18%

+488.70K

+2.70%

Dec 31, 2024

State Street Global Advisors (US)

15.31M

4.27%

+255.30K

+1.70%

Dec 31, 2024

T. Rowe Price Associates, Inc.

13.96M

3.9%

-133.51K

-0.95%

Dec 31, 2024

Fidelity Management & Research Company LLC

10.49M

2.93%

-117.40K

-1.11%

Dec 31, 2024

Geode Capital Management, L.L.C.

7.76M

2.17%

+243.80K

+3.25%

Dec 31, 2024

Capital World Investors

7.43M

2.07%

+11.93K

+0.16%

Dec 31, 2024

Invesco Capital Management (QQQ Trust)

7.37M

2.06%

+98.84K

+1.36%

Feb 28, 2025

JP Morgan Asset Management

7.22M

2.01%

+123.15K

+1.74%

Dec 31, 2024

Fisher Investments

4.87M

1.36%

+86.49K

+1.81%

Dec 31, 2024

持股ETF

更新時間: 4月1日週二

機構名稱

佔比

Langar Global HealthTech ETF

19.52%

iShares U.S. Medical Devices ETF

16.03%

Global X Robotics & Artificial Intelligence ETF

11.55%

First Trust Nasdaq Lux Digi Health Solutions ETF

8.42%

Invesco AI and Next Gen Software ETF

7.04%

Franklin Intelligent Machines ETF

6.73%

Goldman Sachs Future Health Care Equity ETF

6.3%

Neuberger Berman Disrupters ETF

6.01%

Inspire 100 ETF

5.52%

iShares Health Innovation Active ETF

5.34%

Langar Global HealthTech ETF

佔比19.52%

iShares U.S. Medical Devices ETF

佔比16.03%

Global X Robotics & Artificial Intelligence ETF

佔比11.55%

First Trust Nasdaq Lux Digi Health Solutions ETF

佔比8.42%

Invesco AI and Next Gen Software ETF

佔比7.04%

Franklin Intelligent Machines ETF

佔比6.73%

Goldman Sachs Future Health Care Equity ETF

佔比6.3%

Neuberger Berman Disrupters ETF

佔比6.01%

Inspire 100 ETF

佔比5.52%

iShares Health Innovation Active ETF

佔比5.34%

分紅派息

近5年累計派現 0.00 美元

公告日期

分紅計劃

股權登記日

現金發放日

除權除息日

暫無數據

拆合股

公告日期

類型

比率

Aug 05, 2021

Split

1>3

公告日期

類型

比率

Aug 05, 2021

Split

1>3

Intuitive Surgical Inc

451.580USD

Intuitive Surgical Inc

451.580

概覽

公司